2013
DOI: 10.1093/eurheartj/eht309.p3827
|View full text |Cite
|
Sign up to set email alerts
|

Left ventricular strain and transmural structural remodeling distribution in hypertensive heart disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
20
2

Year Published

2017
2017
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(23 citation statements)
references
References 0 publications
1
20
2
Order By: Relevance
“…These findings are probably the consequence of myocardial hypertrophy and interstitial fibrosis. Our results suggest that hypertensive heart disease develops in the endocardium—epicardium direction, as it was previously described in animal studies . In conclusion, longitudinal strain could be a surrogate marker of subendocardial fibrosis and a useful parameter for risk stratification in hypertensive patients.…”
Section: Rv Strain In White Coat and Masked Hypertensionsupporting
confidence: 85%
“…These findings are probably the consequence of myocardial hypertrophy and interstitial fibrosis. Our results suggest that hypertensive heart disease develops in the endocardium—epicardium direction, as it was previously described in animal studies . In conclusion, longitudinal strain could be a surrogate marker of subendocardial fibrosis and a useful parameter for risk stratification in hypertensive patients.…”
Section: Rv Strain In White Coat and Masked Hypertensionsupporting
confidence: 85%
“…A previous study using a rat model showed that GLS progressively decreased in hypertensive disease from the early stage up to HF; however GCS was preserved and began to decrease with further pathologic aggravation 17 . The decrease in GLS and GCS was found to be associated with the amount of fibrosis and qualitative abnormality in the endocardium and middle myocardium, respectively 23 . Although not significant, GLS in RA tended to be lower than that of the control group in our study.…”
Section: Discussioncontrasting
confidence: 59%
“…A recent study by Rai et al [14] demonstrated that riociguat ameliorated RV ejection fraction and reduced RV fibrosis even under the high pulmonary systolic pressure in a model of pressure overload RV hypertrophy induced by pulmonary artery banding, supporting our data. Ishizu et al [15] reported that LV longitudinal strain could be a surrogate of subendocardial fibrotic change and may be useful for the risk stratification of hypertensive heart failure. If this also applies to the right ventricle, riociguat may ameliorate fibrotic remodeling in patients with PAH, resulting in improved RV longitudinal strain.…”
Section: Discussionmentioning
confidence: 99%